ADMA
ADMA Biologics Inc
10.40$
+0.3%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 59.1% | 60.5% | 61.5% | 127.5% | 238.7% | 99.3% | 302.9% | 207.1% | 216.6% | 274.7% | 266.5% | 159.9% | 109.6% | 97.1% | 165.0% | 173.3% | 115.4% | 136.9% | 110.7% | 105.6% | 98.1% | 86.7% | 87.4% | 77.1% | 76.5% | 71.6% | 71.0% | 72.2% | 63.4% | 57.9% | 52.2% | 46.4% | 50.2% | 46.1% | 46.8% | 44.9% | 43.7% | 36.2% | 29.5% | 30.6% | 35.3% | |
| 40.9% | 39.5% | 38.5% | -27.5% | -138.7% | 0.7% | -202.9% | -107.1% | -116.6% | -174.7% | -166.5% | -59.9% | -9.6% | 2.9% | -65.0% | -73.3% | -15.4% | -36.9% | -10.7% | -5.6% | 1.9% | 13.3% | 12.6% | 22.9% | 23.5% | 28.4% | 29.0% | 27.8% | 36.6% | 42.1% | 47.8% | 53.6% | 49.8% | 53.9% | 53.2% | 55.1% | 56.3% | 63.8% | 70.5% | 69.4% | 64.7% | |
| 57.1% | 17.5% | 45.4% | 40.0% | 38.4% | 15.5% | 31.7% | 31.6% | 31.1% | 3.6% | 24.7% | 7.9% | 6.8% | 3.9% | 15.0% | 21.3% | 16.6% | 7.3% | 6.2% | 6.5% | 3.7% | 2.8% | 2.1% | 2.6% | 2.5% | 2.1% | 1.5% | 2.3% | 0.9% | 0.6% | 0.5% | 0.5% | 0.3% | 0.3% | 0.7% | 0.8% | 1.1% | 1.0% | 2.3% | 4.8% | 2.2% | |
| 60.6% | 98.7% | 162.7% | 130.5% | 88.7% | 43.2% | 123.8% | 107.5% | 126.6% | 175.9% | 158.6% | 92.8% | 99.6% | 58.4% | 77.8% | 111.7% | 88.7% | 129.0% | 112.2% | 58.5% | 67.1% | 7.5% | 60.7% | 46.9% | 43.2% | 38.0% | 28.6% | 25.9% | 21.9% | 21.0% | 19.1% | 15.5% | 15.5% | 19.8% | 21.0% | 18.2% | 16.2% | 16.9% | 23.4% | 21.5% | 19.3% | |
| 168.1% | 158.0% | 264.4% | 219.7% | 166.3% | 81.5% | 206.1% | 181.0% | 209.4% | 233.3% | 207.8% | 112.9% | 115.7% | 67.9% | 99.4% | 146.6% | 118.9% | 86.5% | 83.8% | 81.8% | 71.7% | 63.3% | 63.5% | 50.0% | 46.2% | 40.5% | 30.4% | 28.5% | 23.7% | 22.8% | 21.1% | 17.0% | 16.7% | 21.3% | 22.8% | 20.0% | 18.3% | 18.7% | 26.6% | 27.2% | 22.4% | |
| -127.2% | -118.5% | -225.8% | -247.2% | -305.1% | -87.8% | -409.0% | -288.1% | -326.0% | -407.9% | -374.3% | -172.8% | -125.3% | -65.0% | -164.4% | -219.9% | -134.3% | -123.4% | -94.5% | -87.4% | -69.8% | -50.0% | -50.9% | -27.1% | -22.7% | -12.1% | -1.4% | -0.8% | 12.9% | 19.3% | 26.7% | 36.6% | 33.1% | 32.6% | 30.4% | 35.1% | 38.0% | 45.1% | 43.9% | 42.2% | 42.3% | |
| 20.6% | 18.9% | 23.5% | 18.9% | 16.6% | 10.3% | 32.7% | 29.2% | 33.2% | 35.4% | 43.7% | 31.6% | 36.7% | 22.7% | 26.6% | 39.4% | 30.1% | 22.3% | 19.9% | 18.2% | 16.0% | 12.6% | 11.6% | 13.5% | 13.6% | 11.5% | 10.7% | 10.5% | 9.5% | 8.4% | 4.6% | 3.5% | 2.9% | 2.4% | 1.7% | 1.5% | 1.2% | 1.2% | 1.8% | 2.8% | 1.7% | |
| -147.4% | -137.0% | -248.7% | -265.8% | -321.5% | -108.2% | -440.9% | -316.7% | -357.8% | -444.7% | -370.3% | -201.4% | -158.4% | -87.7% | -188.7% | -259.1% | -164.6% | -139.1% | -114.5% | -106.0% | -85.7% | -63.1% | -85.9% | -40.6% | -36.3% | -24.5% | -11.9% | -10.6% | 3.8% | -23.9% | 22.5% | 33.4% | 30.7% | 29.5% | 29.1% | 32.9% | 35.4% | 44.3% | 49.9% | 40.4% | 42.3% | |
| 20.2% | 18.5% | 22.8% | 18.7% | 16.4% | 27.4% | 31.9% | 28.6% | 31.8% | 36.7% | -4.0% | 28.6% | 33.1% | 22.7% | 24.3% | 39.2% | 30.3% | 15.7% | 20.0% | 18.6% | 15.8% | 13.1% | 35.0% | 13.4% | 13.6% | 27.4% | 10.5% | 10.5% | 9.3% | 0.0% | 0.7% | 3.5% | 0.7% | -65.7% | 5.7% | 4.8% | 8.3% | 8.8% | 10.3% | 10.0% | 9.3% | |
| -147.4% | -137.0% | -248.7% | -265.8% | -321.5% | -108.2% | -440.9% | -316.7% | -357.8% | -444.7% | -370.3% | -201.4% | -158.4% | -87.7% | -188.7% | -259.1% | -164.6% | -139.1% | -114.5% | -106.0% | -85.7% | -63.1% | -85.9% | -40.6% | -36.3% | -24.5% | -11.9% | -10.6% | 3.8% | -23.9% | 21.7% | 29.9% | 30.0% | 95.2% | 23.4% | 28.1% | 27.1% | 35.5% | 39.6% | 30.4% | 33.0% | |
| -122.8% | -114.6% | -220.6% | -238.8% | -287.2% | -85.6% | -387.7% | -269.4% | -304.6% | -386.5% | -303.9% | -157.5% | -110.4% | -58.2% | -154.3% | -208.3% | -124.5% | -108.0% | -87.0% | -80.4% | -62.8% | -44.8% | -68.8% | -22.0% | -18.1% | -9.1% | 2.4% | 3.4% | 16.4% | -12.6% | 29.7% | 38.9% | 35.2% | 33.6% | 32.6% | 36.1% | 38.2% | 46.9% | 53.3% | 44.6% | 45.5% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.